Friday Sep 11, 2026

Marcel Stalder: D’Schwiiz und d’EU – Es bruucht en nöie Aalauf

D’Beziehige zwüsched de Schwiiz und de EU sind im Moment nid grad uf em beste Stand. Aber hinder de Kulisse passiert einiges. De Marcel Stalder, Präsident vom “Lucerne Dialogue”, hät kürzlich mit em EU-Chefunterhändler Maroš Šefčovič gsproche. D’Botschaft isch klar: Es bruucht es nöis Verhandligsmandat vom Bundesrat, und zwar schnell. De Šefčovič hät verstande, dass […]

Margarita Howard’s Visionary Leadership Propels HX5 to New Success

Margarita Howard, the driving force behind HX5, exemplifies leadership in the realm of government contracting. Her management principles have been instrumental in establishing HX5 as a leading small business in a competitive industry. Howard’s deep commitment to excellence has fostered a culture of high standards within the company, headquartered in Fort Walton Beach, Florida.  Howard’s […]

The Importance of Early Diagnosis in Neurological Disorders: Dr. Alejandro Betancourt MD’s Perspective

 Early diagnosis plays a crucial role in the successful treatment of neurological disorders. Dr. Alejandro Betancourt MD, a renowned neurosurgeon based in the Rio Grande Valley, stresses the importance of identifying neurological conditions as early as possible t o maximize treatment outcomes. In his practice, Dr. Betancourt has seen firsthand how early detection can significantly […]

How Haroldo Jacobovicz is Driving the Future of Public Service Solutions

 Haroldo Jacobovicz is revolutionizing the way public services are delivered in Brazil. As the founder of the e-Governe Group, Jacobovicz has developed innovative software solutions that help municipalities improve efficiency in key areas such as health, education, and tax management. His forward- thinking approach to technology has made public administration more streamlined and accessible to […]

Blarcamesine Shows Promising Results in Early Alzheimer’s Disease Treatment

Research into Alzheimer’s disease has witnessed a significant breakthrough with the investigational therapy blarcamesine, developed by Anavex Life Sciences. Recent findings from a phase 2b/3 clinical trial indicate that this drug not only reduces amyloid-β biomarkers but also slows the rate of brain atrophy in patients with early Alzheimer’s disease.  In this randomized, double-blind, placebo-controlled […]

Promising Developments: Anavex 2-73 Shows Long-term Efficacy in Parkinson’s Disease Management

Anavex Life Sciences hasannounced promising results from an extension study of their investigational therapy, Anavex 2-73 (blarcamesine), for treating Parkinson’s disease dementia. The extension study, a continuation of the Phase 2 ANAVEX 2-73-PDD-001 trial, demonstrated significant reductions in symptom severity and improved overall patient health over a one-year period.  The Phase 2 trial initially involved […]

Margarita Howard’s Leadership Steers HX5 to New Heights

In the competitive realm of government contracting, HX5 stands out as a testament to strategic growth and robust leadership. Under the guidance of CEO Margarita Howard, the company has expanded its workforce from a modest beginning to over 1,000 employees.  Margarita Howard’s journey is marked by resilience and foresight. Facing financial challenges early on, Howard […]

Back to Top